Literature DB >> 23563632

The flow dependency of Tie2 expression in endotoxemia.

Neng F Kurniati1, Rianne M Jongman, Franziska vom Hagen, Katherine C Spokes, Jill Moser, Erzsébet Ravasz Regan, Guido Krenning, Jan-Renier A J Moonen, Martin C Harmsen, Michel M R F Struys, Hans-Peter Hammes, Jan G Zijlstra, William C Aird, Peter Heeringa, Grietje Molema, Matijs van Meurs.   

Abstract

RATIONALE: Tie2 is predominantly expressed by endothelial cells and is involved in vascular integrity control during sepsis. Changes in Tie2 expression during sepsis development may contribute to microvascular dysfunction. Understanding the kinetics and molecular basis of these changes may assist in the development of therapeutic intervention to counteract microvascular dysfunction.
OBJECTIVE: To investigate the molecular mechanisms underlying the changes in Tie2 expression upon lipopolysaccharide (LPS) challenge. METHODS AND
RESULTS: Studies were performed in LPS and pro-inflammatory cytokine challenged mice as well as in mice subjected to hemorrhagic shock, primary endothelial cells were used for in vitro experiments in static and flow conditions. Eight hours after LPS challenge, Tie2 mRNA loss was observed in all major organs, while loss of Tie2 protein was predominantly observed in lungs and kidneys, in the capillaries. A similar loss could be induced by secondary cytokines TNF-α and IL-1β. Ang2 protein administration did not affect Tie2 protein expression nor was Tie2 protein rescued in LPS-challenged Ang2-deficient mice, excluding a major role for Ang2 in Tie2 down regulation. In vitro, endothelial loss of Tie2 was observed upon lowering of shear stress, not upon LPS and TNF-α stimulation, suggesting that inflammation related haemodynamic changes play a major role in loss of Tie2 in vivo, as also hemorrhagic shock induced Tie2 mRNA loss. In vitro, this loss was partially counteracted by pre-incubation with a pharmacologically NF-кB inhibitor (BAY11-7082), an effect further substantiated in vivo by pre-treatment of mice with the NF-кB inhibitor prior to the inflammatory challenge.
CONCLUSIONS: Microvascular bed specific loss of Tie2 mRNA and protein in vivo upon LPS, TNFα, IL-1β challenge, as well as in response to hemorrhagic shock, is likely an indirect effect caused by a change in endothelial shear stress. This loss of Tie2 mRNA, but not Tie2 protein, induced by TNFα exposure was shown to be controlled by NF-кB signaling. Drugs aiming at restoring vascular integrity in sepsis could focus on preventing the Tie2 loss.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563632     DOI: 10.1007/s00134-013-2899-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  33 in total

1.  Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues.

Authors:  A L Wong; Z A Haroon; S Werner; M W Dewhirst; C S Greenberg; K G Peters
Journal:  Circ Res       Date:  1997-10       Impact factor: 17.367

Review 2.  Vascular heterogeneity in the kidney.

Authors:  Grietje Molema; William C Aird
Journal:  Semin Nephrol       Date:  2012-03       Impact factor: 5.299

3.  PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice.

Authors:  Mei Tran; Denise Tam; Amit Bardia; Manoj Bhasin; Glenn C Rowe; Ajay Kher; Zsuzsanna K Zsengeller; M Reza Akhavan-Sharif; Eliyahu V Khankin; Magali Saintgeniez; Sascha David; Deborah Burstein; S Ananth Karumanchi; Isaac E Stillman; Zoltan Arany; Samir M Parikh
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

4.  Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization.

Authors:  Elena Bogdanovic; Vicky P K H Nguyen; Daniel J Dumont
Journal:  J Cell Sci       Date:  2006-08-08       Impact factor: 5.285

Review 5.  Sepsis and cytokines: current status.

Authors:  T S Blackwell; J W Christman
Journal:  Br J Anaesth       Date:  1996-07       Impact factor: 9.166

6.  Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function.

Authors:  Matijs van Meurs; Neng F Kurniati; Francis M Wulfert; Sigridur A Asgeirsdottir; Inge A de Graaf; Simon C Satchell; Peter W Mathieson; Rianne M Jongman; Philipp Kümpers; Jan G Zijlstra; Peter Heeringa; Grietje Molema
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-10

7.  Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy.

Authors:  Sang Won Park; Sean W C Chen; Mihwa Kim; Kevin M Brown; Jay K Kolls; Vivette D D'Agati; H Thomas Lee
Journal:  Lab Invest       Date:  2010-08-09       Impact factor: 5.662

8.  COMP-angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury.

Authors:  Duk Hoon Kim; Yu Jin Jung; Ae Sin Lee; Sik Lee; Kyung Pyo Kang; Tae Hwan Lee; Sang Yong Lee; Kyu Yun Jang; Woo Sung Moon; Kyu-Sil Choi; Kwon-Ha Yoon; Mi Jeong Sung; Sung Kwang Park; Won Kim
Journal:  Kidney Int       Date:  2009-10-07       Impact factor: 10.612

9.  Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.

Authors:  Hitoshi Takagi; Shinji Koyama; Hisayuki Seike; Hideyasu Oh; Atsushi Otani; Miyo Matsumura; Yoshihito Honda
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-01       Impact factor: 4.799

10.  Angiopoietin-1 treatment reduces inflammation but does not prevent ventilator-induced lung injury.

Authors:  Maria A Hegeman; Marije P Hennus; Matijs van Meurs; Pieter M Cobelens; Annemieke Kavelaars; Nicolaas J Jansen; Marcus J Schultz; Adrianus J van Vught; Grietje Molema; Cobi J Heijnen
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

View more
  22 in total

Review 1.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

2.  Molecular Regulation of Acute Tie2 Suppression in Sepsis.

Authors:  Kristina Thamm; Claudia Schrimpf; Jennifer Retzlaff; Temitayo O Idowu; Matijs van Meurs; Jan G Zijlstra; Chandra C Ghosh; Jana Zeitvogel; Thomas A Werfel; Hermann Haller; Samir M Parikh; Sascha David
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

Review 3.  Angiopoietins and Tie2 in vascular inflammation.

Authors:  Samir M Parikh
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

Review 4.  Signaling pathways and intervention therapies in sepsis.

Authors:  Yun-Yu Zhang; Bo-Tao Ning
Journal:  Signal Transduct Target Ther       Date:  2021-11-25

Review 5.  Renal microvascular endothelial cell responses in sepsis-induced acute kidney injury.

Authors:  Grietje Molema; Jan G Zijlstra; Matijs van Meurs; Jan A A M Kamps
Journal:  Nat Rev Nephrol       Date:  2021-10-19       Impact factor: 28.314

6.  Pattern of tamoxifen-induced Tie2 deletion in endothelial cells in mature blood vessels using endo SCL-Cre-ERT transgenic mice.

Authors:  Peter J Zwiers; Rianne M Jongman; Timara Kuiper; Jill Moser; Radu V Stan; Joachim R Göthert; Matijs van Meurs; Eliane R Popa; Grietje Molema
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

7.  Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema.

Authors:  Xinguo Jiang; Wen Tian; Eric J Granucci; Allen B Tu; Dongeon Kim; Petra Dahms; Shravani Pasupneti; Gongyong Peng; Yesl Kim; Amber H Lim; F Hernan Espinoza; Matthew Cribb; J Brandon Dixon; Stanley G Rockson; Gregg L Semenza; Mark R Nicolls
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

8.  Gene control of tyrosine kinase TIE2 and vascular manifestations of infections.

Authors:  Chandra C Ghosh; Sascha David; Ruyang Zhang; Anthony Berghelli; Katelyn Milam; Sarah J Higgins; Jon Hunter; Aditi Mukherjee; Yongyue Wei; Mei Tran; Freeman Suber; Lester Kobzik; Kevin C Kain; Shulin Lu; Ansgar Santel; Kiichiro Yano; Prajna Guha; Daniel J Dumont; David C Christiani; Samir M Parikh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

9.  Tie1 controls angiopoietin function in vascular remodeling and inflammation.

Authors:  Emilia A Korhonen; Anita Lampinen; Hemant Giri; Andrey Anisimov; Minah Kim; Breanna Allen; Shentong Fang; Gabriela D'Amico; Tuomas J Sipilä; Marja Lohela; Tomas Strandin; Antti Vaheri; Seppo Ylä-Herttuala; Gou Young Koh; Donald M McDonald; Kari Alitalo; Pipsa Saharinen
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

10.  Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients.

Authors:  Meint Volbeda; Daniela Jou-Valencia; Marius C van den Heuvel; Marjolein Knoester; Peter J Zwiers; Janesh Pillay; Stefan P Berger; Peter H J van der Voort; Jan G Zijlstra; Matijs van Meurs; Jill Moser
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.